Schroders Capital, the private markets division of Schroders Group, has secured over $2.6 billion for direct and co-investments in private equity since January 2022.
This achievement has been bolstered by the recent €400 million close of Schroders Capital Private Equity Europe Direct III, one of its leading European buyout funds focusing on small to mid-sized buyouts.
Europe Direct III has attracted a range of global investors, including pension funds, insurance companies, endowments, foundations and family offices. According to the firm, clients have shown increasing interest in the fund, drawn to the growth potential of European small and medium-sized enterprises.
AXA IM Alts acquires Capza, expands into private equity
The firm’s recent exits include PSS, Olink and Intellera, with these sales generating over 8x the invested capital in aggregate. Among these, Olink, a Swedish life sciences company, stands out as a key success. Schroders Capital, alongside Summa Equity, helped drive Olink’s expansion through significant R&D investments and the launch of new proprietary technologies. The exit from Olink in July marked Schroders Capital’s largest private equity liquidity event, with proceeds exceeding $325 million.
Richard Damming, head of European private equity investments at Schroders Capital, said: “The successful closing of Europe Direct III is a testament to our team’s dedication and track record of creating value for our investors. We’re pleased with the growth we’ve seen in direct and co-investments.”
